Dondurei E A, Osidak L V, Golovacheva E G, Golovanova A K, Amosova I V, Gladchenko L N
Institute of Influenza, Russian Academy of Medical Sciences, St. Petersburg.
Bull Exp Biol Med. 2009 Aug;148(2):283-6. doi: 10.1007/s10517-009-0700-2.
We evaluated the percent of acute respiratory viral infections with gastrointestinal syndrome in the structure of morbidity in babies aging 6 months and elder. Therapeutic efficiency and safety of anaferon (pediatric formuation) as a component of complex therapy of acute respiratory viral infections with involvement of the gastrointestinal tract were proven; more rapid disappearance of all symptoms and improvement of the immune status parameters were demonstrated.
我们评估了6个月及以上婴儿发病率结构中伴有胃肠道综合征的急性呼吸道病毒感染的百分比。已证实,作为伴有胃肠道受累的急性呼吸道病毒感染综合治疗组成部分的安福隆(儿科剂型)的治疗效果和安全性;所有症状更快消失,免疫状态参数得到改善。